MEGAN WHISMAN: Open Payments
NPI 1598168320 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 96 payments from 21 companies in 2025. Trend: 2023 $1,085 · 2024 $1,286 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $337 |
| Gilead Sciences, Inc. | 9 | $219 |
| Novo Nordisk Inc | 11 | $163 |
| ViiV Healthcare Company | 3 | $151 |
| Otsuka America Pharmaceutical, Inc. | 6 | $102 |
| Braeburn Inc. | 5 | $98 |
| Lundbeck LLC | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
Products named: REXULTI, APRETUDE, Yeztugo, VRAYLAR, BRIXADI, MAVYRET, UBRELVY, Kerendia.
Industry payments across OH — which companies pay providers there.
